Patent classifications
A23J1/18
PROTEIN PRODUCT FROM PLANTS AND YEASTS AND PRODUCTION PROCESS FOR SAME
A process for producing a protein product from plants and yeasts comprises providing a thin stillage or a thin stillage concentrate; separating a protein concentrate from the thin stillage; diluting the protein concentrate to a dry substance content of at most 15 wt.%, tempering the diluted protein concentrate to at least 60° C., and adjusting the pH of the diluted and tempered protein concentrate to alkaline; cooling the processed protein concentrate and subsequently separating a liquid phase; adjusting the pH of the separated liquid phase to an acidic pH, and then separating a solid phase; and dispersing the solid phase in a solvent and subsequently separating a product phase, wherein the product phase comprises the protein product from plants and yeasts.
PROTEIN PRODUCT FROM PLANTS AND YEASTS AND PRODUCTION PROCESS FOR SAME
A process for producing a protein product from plants and yeasts comprises providing a thin stillage or a thin stillage concentrate; separating a protein concentrate from the thin stillage; diluting the protein concentrate to a dry substance content of at most 15 wt.%, tempering the diluted protein concentrate to at least 60° C., and adjusting the pH of the diluted and tempered protein concentrate to alkaline; cooling the processed protein concentrate and subsequently separating a liquid phase; adjusting the pH of the separated liquid phase to an acidic pH, and then separating a solid phase; and dispersing the solid phase in a solvent and subsequently separating a product phase, wherein the product phase comprises the protein product from plants and yeasts.
Methods and compositions for egg white protein production
Provided herein are compositions, proteins, polynucleotides, expression vectors, host cells, kits, and systems for producing egg white proteins, as well as methods of using the same.
Methods and compositions for egg white protein production
Provided herein are compositions, proteins, polynucleotides, expression vectors, host cells, kits, and systems for producing egg white proteins, as well as methods of using the same.
COMPOSITIONS FOR PREPARING ANIMAL-FREE EGG-LIKE PRODUCTS
The present disclosure provides compositions for preparation of egg-like products.
COMPOSITIONS FOR PREPARING ANIMAL-FREE EGG-LIKE PRODUCTS
The present disclosure provides compositions for preparation of egg-like products.
Yeast proteins
The present invention relates to a method for obtaining yeast proteins comprising the following steps: a) providing a yeast cream; b) exposing this yeast cream to a thermal plasmolysis at a temperature between 70 and 95° C. for a period between 30 seconds and 4 hours, preferably between 1 minute and 3 hours, more preferably between 40 minutes and 2 hours; b′) separating the insoluble fraction and the soluble fraction; c) subjecting the insoluble fraction to the activity of at least one ribonuclease and a glucanase, sequentially or simultaneously, at a temperature between 40 and 65° C., preferably 60° C., for a period between 8 and 24 hours, preferably 18 hours; d) separating the insoluble fraction from the soluble fraction; wherein the insoluble fraction collected in step d) has no taste, having a nucleotide content less than 3% and a true protein content of at least 72%. Step b′) is optional. In this case, the entirety of the composition obtained after thermal plasmolysis of the yeast cream is subjected to enzymatic activity.
Yeast proteins
The present invention relates to a method for obtaining yeast proteins comprising the following steps: a) providing a yeast cream; b) exposing this yeast cream to a thermal plasmolysis at a temperature between 70 and 95° C. for a period between 30 seconds and 4 hours, preferably between 1 minute and 3 hours, more preferably between 40 minutes and 2 hours; b′) separating the insoluble fraction and the soluble fraction; c) subjecting the insoluble fraction to the activity of at least one ribonuclease and a glucanase, sequentially or simultaneously, at a temperature between 40 and 65° C., preferably 60° C., for a period between 8 and 24 hours, preferably 18 hours; d) separating the insoluble fraction from the soluble fraction; wherein the insoluble fraction collected in step d) has no taste, having a nucleotide content less than 3% and a true protein content of at least 72%. Step b′) is optional. In this case, the entirety of the composition obtained after thermal plasmolysis of the yeast cream is subjected to enzymatic activity.
Genetically engineered strain for producing porcine myoglobin and food-grade fermentation and purification thereof
The disclosure discloses a genetically engineered strain for producing porcine myoglobin and fermentation and purification thereof, and belongs to the technical field of genetic engineering. The disclosure realizes efficient secretion and expression of porcine myoglobin by integrating the gene of porcine myoglobin in P. pastoris. On this basis, optimization of the medium and culture conditions of recombinant P. pastoris can significantly increase the titer of porcine myoglobin, so that the titer can reach 285.42 mg/L under fermenter conditions. In addition, by creatively adding different concentrations of ammonium sulfate to fermentation broth step by step, the purity of myoglobin obtained by final concentration is up to 88.0%, and the purification rate is up to 66.1%. The disclosure realizes efficient expression and high purification of porcine myoglobin from various steps such as synthesis, fermentation and purification of porcine myoglobin, and provides broad prospects for industrial production of porcine myoglobin.
Genetically engineered strain for producing porcine myoglobin and food-grade fermentation and purification thereof
The disclosure discloses a genetically engineered strain for producing porcine myoglobin and fermentation and purification thereof, and belongs to the technical field of genetic engineering. The disclosure realizes efficient secretion and expression of porcine myoglobin by integrating the gene of porcine myoglobin in P. pastoris. On this basis, optimization of the medium and culture conditions of recombinant P. pastoris can significantly increase the titer of porcine myoglobin, so that the titer can reach 285.42 mg/L under fermenter conditions. In addition, by creatively adding different concentrations of ammonium sulfate to fermentation broth step by step, the purity of myoglobin obtained by final concentration is up to 88.0%, and the purification rate is up to 66.1%. The disclosure realizes efficient expression and high purification of porcine myoglobin from various steps such as synthesis, fermentation and purification of porcine myoglobin, and provides broad prospects for industrial production of porcine myoglobin.